Sign In
25 Jul 2019 07:00
25 July 2019
Â
Consort Medical plc
Â
Notification of Transactions of Directors or
Persons Discharging Managerial Responsibility and Connected Persons
Â
Â
Â
On 24 July 2019, pursuant to the rules of the Consort Medical plc Deferred Bonus Plan, the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares in the Company ("Ordinary Shares") at a share price of ÂŁ7.85 each as detailed below:
Â
Â
Deferred Bonus Share Award (in respect of the financial year 2018/19)
Â
Director/PDMR | Number of Ordinary Shares awarded |
Jonathan Glenn | 17,216 |
Paul Hayes | 9,966 |
Keyvan Djamarani | 5,985 |
Manja Boerman | 3,840 |
Â
Â
Each award was granted as a nil cost option.
Â
Enquiries: Andrew Jackson, Company Secretary 01442 867920
Â
1  | Details of the person discharging managerial responsibilities / person closely associated  | ||||
a)  | Name   | Jonathan Glenn  | |||
2  | Reason for the notification  | ||||
a)  | Position/status   | CEO | |||
b)  | Initial notification /Amendment   | Initial notification | |||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | ||||
a)  | Name   | Consort Medical plc | |||
b) Â | LEI Â Â | 2138001TBP74FD66QT38 | |||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   | ||||
a) Â | Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)  | Nature of the transaction   | Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan (DBP) | |||
c) Â | Price(s) and volume(s) | Â | Â | Â | Â |
 | Price(s) | Volume(s) |  | ||
 | 0 | 17,216  |  | ||
 |  |  |  | ||
d) Â | Aggregated information | n/a | |||
- Aggregated volume | |||||
- Price | |||||
e)  | Date of the transaction   | 24 July 2019 | |||
f)  | Place of the transaction  | Off market transaction | |||
1  | Details of the person discharging managerial responsibilities / person closely associated  | ||||
a)  | Name   | Keyvan Djamarani | |||
2  | Reason for the notification  | ||||
a)  | Position/status   | President Bespak | |||
b)  | Initial notification /Amendment   | Initial notification | |||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | ||||
a)  | Name   | Consort Medical plc | |||
b) Â | LEI Â Â | 2138001TBP74FD66QT38 | |||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   | ||||
a) Â | Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)  | Nature of the transaction   | Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan  | |||
c) Â | Price(s) and volume(s) | Â | Â | Â | Â |
 | Price(s) | Volume(s) |  | ||
 | 0 | 5,985 |  | ||
 |  |  |  | ||
d) Â | Aggregated information | n/a | |||
- Aggregated volume | |||||
- Price | |||||
e)  | Date of the transaction   |  24 July 2019 | |||
f)  | Place of the transaction  | Off market transaction | |||
1  | Details of the person discharging managerial responsibilities / person closely associated  | ||||
a)  | Name   | Manja Boerman | |||
2  | Reason for the notification  | ||||
a)  | Position/status   | President Aesica | |||
b)  | Initial notification /Amendment   | Initial notification | |||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | ||||
a)  | Name   | Consort Medical plc | |||
b) Â | LEI Â Â | 2138001TBP74FD66QT38 | |||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   | ||||
a) Â | Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)  | Nature of the transaction   | Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan (DBP) | |||
c) Â | Price(s) and volume(s) | Â | Â | Â | Â |
 | Price(s) | Volume(s) |  | ||
 | 0 | 3,840 |  | ||
 |  |  |  | ||
d) Â | Aggregated information | n/a | |||
- Aggregated volume | |||||
- Price | |||||
e)  | Date of the transaction   |  24 July 2019 | |||
f)  | Place of the transaction  | Off market transaction | |||
1  | Details of the person discharging managerial responsibilities / person closely associated  | ||||
a)  | Name   | Paul Hayes | |||
2  | Reason for the notification  | ||||
a)  | Position/status   | CFO | |||
b)  | Initial notification /Amendment   | Initial notification | |||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | ||||
a)  | Name   | Consort Medical plc | |||
b) Â | LEI Â Â | 2138001TBP74FD66QT38 | |||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   | ||||
a) Â | Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)  | Nature of the transaction   | Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan (DBP) | |||
c) Â | Price(s) and volume(s) | Â | Â | Â | Â |
 | Price(s) | Volume(s) |  | ||
 | 0 | 9,966 |  | ||
 |  |  |  | ||
d) Â | Aggregated information | n/a | |||
- Aggregated volume | |||||
- Price | |||||
e)  | Date of the transaction   | 24 July 2019 | |||
f)  | Place of the transaction  | Off market transaction | |||
Â
Follow the stocks
